|
1
|
Baek D, Villén J, Shin C, et al: The
impact of microRNAs on protein output. Nature. 455:64–71. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Eulalio A, Huntzinger E and Izaurralde E:
Getting to the root of miRNA-mediated gene silencing. Cell.
132:9–14. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Calin GA, Dumitru CD, Shimizu M, Bichi R,
et al: Frequent deletions and down-regulation of microRNA genes
miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl
Acad Sci USA. 99:15524–15529. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Calin GA, Ferracin M, Cimmino A, Di Leva
G, et al: A MicroRNA signature associated with prognosis and
progression in chronic lymphocytic leukemia. N Engl J Med.
353:1793–1801. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Michael MZ, O’Conner SM, van Holst
Pellekaan NG, Young GP and James RJ: Reduced accumulation of
specific microRNAs in colorectal neoplasia. Mol Cancer Res.
1:882–891. 2003.PubMed/NCBI
|
|
8
|
Pfeffer S, Zavolan M, Grasser FA, Chien M,
et al: Identification of virus-encoded microRNAs. Science.
304:734–736. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hwang H and Mendell J: MicroRNAs in cell
proliferation, cell death and tumorigenesis. Br J Cancer.
94:776–780. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen C, Li L, Lodish H and Bartel D:
MicroRNAs modulate hematopoietic lineage differentiation. Science.
303:83–86. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chan JA, Krichevsky AM and Kosik KS:
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.
Cancer Res. 65:6029–6033. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yanaihara N, Caplen N, Bowman E, Seike M,
et al: Unique microRNA molecular profiles in lung cancer diagnosis
and prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Markou A, Tsaroucha EG, Kaklamanis L, et
al: Prognostic value of mature microRNA-21 and microRNA-205
overexpression in non-small cell lung cancer by quantitative
real-time RT-PCR. Clin Chem. 54:1696–1704. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Volinia S, Calin GA, Liu CG, Ambs S, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Slaby O, Svoboda M, Fabian P, Smerdova T,
et al: Altered expression of miR-21, miR-31, miR-143 and miR-145 is
related to clinicopathologic features of colorectal cancer.
Oncology. 72:397–402. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schetter AJ, Leung SY, Sohn JJ, Zanetti
KA, et al: MicroRNA expression profiles associated with prognosis
and therapeutic outcome in colonadenocarcinoma. JAMA. 299:425–436.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Meng F, Henson R, Lang M, Wehbe H, et al:
Involvement of human micro-RNA in growth and response to
chemotherapy in human cholangiocarcinoma cell lines.
Gastroenterology. 130:2113–2129. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Papadopoulos GL, Reczko M, Simossis VA,
Sethupathy P and Hatzigeorgiou AG: The database of experimentally
supported targets: a functional update of TarBase. Nucleic Acids
Res. 37:D155–D158. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Selcuklu SD, Donoghue MT and Spillane C:
miR-21 as a key regulator of oncogenic processes. Biochem Soc
Trans. 37:918–925. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ashcroft GS, Yang X, Glick AB, Weinstein
M, et al: Mice lacking Smad3 show accelerated wound healing and an
impaired local inflammatory response. Nat Cell Biol. 1:260–266.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Attisano L and Wrana JL: Smads as
transcriptional co-modulators. Curr Opin Cell Biol. 12:235–243.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Attisano L and Wrana JL: Signal
transduction by the TGF-beta superfamily. Science. 296:1646–1647.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hayashi H, Abdollah S, Qiu Y, et al: The
SMAD-related protein SMAD7 associates with the TGF beta receptor
and functions as an antagonist of TGF beta signaling. Cell.
89:1165–1173. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kavsak P, Rasmussen RK, Causing CG, et al:
SMAD7 binds to Smurf 2 to form an E3 ubiquitin ligase that targets
the TGF beta receptor for degradation. Mol Cell. 6:1365–1375. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Karp X and Ambros V: Encountering
microRNAs in cell fate signaling. Science. 310:1288–1289. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen CZ, Li L, Lodish HF and Bartel DP:
MicroRNAs modulate hematopoietic lineage differentiation. Science.
303:83–86. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Heldin CH, Miyazono K and ten Dijke P:
TGF-beta signaling from cell membrane to nucleus through SMAD
proteins. Nature. 390:465–471. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Massague J and Wotton D: Transcriptional
control by the TGF-beta/Smad signaling system. EMBO J.
19:1745–1754. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhu H, Li Y, Qu S, et al: MicroRNA
expression abnormalities in limited cutaneous scleroderma and
diffuse cutaneous scleroderma. J Clin Immunol. 32:514–522. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wei J, Feng L, Li Z, Xu G and Fan X:
MicroRNA-21 activates hepatic stellate cells via PTEN/Akt
signaling. Biomed Pharmacother. 67:387–392. 2013. View Article : Google Scholar : PubMed/NCBI
|
